CANbridge Pharmaceuticals Inc CNBRF
CNBRF Shariah Compliance
Screening Methodology: AAOIFI
As of August 2026, CANbridge Pharmaceuticals Inc is classified as not halal.
NOT HALAL
Report Source: undefined Quarter Report
CANbridge Pharmaceuticals Inc. Stock Analysis CNBRF
United States Health Care Micro Cap CANbridge Pharmaceuticals Inc. operates as a rare disease-focused biopharmaceutical company committed to the research, development and commercialization of transformative therapies. The company is headquartered in Cambridge, Massachusetts and currently employs 45 full-time employees. The company went IPO on 2021-12-10. The company is focused on research, development and commercialization of transformative therapies for rare disease. The company has a drug portfolio, with three approved drugs and a pipeline of eight assets, targeting rare disease indications that have unmet needs. These include Hunter syndrome and other lysosomal storage disorders, paroxysmal nocturnal hemoglobinuria and other complement-mediated disorders, hemophilia A, metabolic disorders, rare cholestatic liver diseases and neuromuscular diseases. Its pipeline includes Hunterase, Livmarli, CAN106, and CAN103. Hunterase is an enzyme replacement therapy for the treatment of Mucopolysaccharidosis type II (MPS II), also known as Hunter syndrome. Livmarli an oral, minimally absorbed, reversible inhibitor of the ileal bile acid transporter that is under development to treat rare cholestatic liver diseases including Alagille syndrome and progressive familial intrahepatic cholestasis.
CANbridge Pharmaceuticals Inc (CNBRF) Chart
Financial Metrics & Statements of CANbridge Pharmaceuticals Inc (CNBRF)
FAQ's for CANbridge Pharmaceuticals Inc (CNBRF)
- As of August 2026, CANbridge Pharmaceuticals Inc CNBRF is classified as not halal according to Musaffa’s Shariah screening methodology. This classification is based on an assessment of the company’s business activities and financial ratios against Islamic investment guidelines.
- A stock is Shariah-compliant if the company operates in permissible business activities and meets Islamic financial screening thresholds. Musaffa analyzes CANbridge Pharmaceuticals Inc using these criteria to determine its compliance status.
- Muslim investors may consider investing in CANbridge Pharmaceuticals Inc if it meets Shariah compliance standards. Investors typically review the company’s business activities, debt levels, and non-permissible income before making a decision.
- Musaffa determines the Shariah status of CANbridge Pharmaceuticals Inc by analyzing whether the company’s core business operations are permissible and whether its financial ratios fall within accepted Islamic thresholds.
- The Shariah compliance status of CANbridge Pharmaceuticals Inc may be updated periodically when new financial statements, earnings reports, or business activity information become available.
- Yes. A stock that is currently Shariah-compliant may become non-compliant if the company’s financial ratios exceed Shariah thresholds or its business activities change.
- You can check the latest Shariah compliance status of CANbridge Pharmaceuticals Inc on Musaffa’s stock page, where screening results and key financial indicators are updated to help Muslim investors make informed decisions.
Alternate Halal Stocks for CANbridge Pharmaceuticals Inc (CNBRF)
Related Halal Stocks are Shariah-compliant companies that align with Islamic investment principles, avoiding prohibited industries like alcohol, gambling, and interest-based finance.
